Treatment as Prevention¨

Le “Consensus de Vancouver”: consŽcration de la prŽvention biomŽdicale du VIH

Ds l’ouverture de la ConfŽrence internationale sur le sida (IAS) de Vancouver, les annonces de la communautŽ des chercheurs ont frappŽ fort. Entre l’appel à une mise sous traitement ds le diagnostic, les futures recommandations de l’OMS sur le traitement prŽventif du VIH (PrEP) et le plaidoyer pour financer cette rŽponse à l’ŽpidŽmie, la premire […]

Le “Consensus de Vancouver”: consŽcration de la prŽvention biomŽdicale du VIH Read More »

We can end AIDS, so let’s do it

Some of the world’s pre-eminent medical professionals, public health experts and scientists have been meeting in Vancouver this week at the 2015 International AIDS Society’s biennial conference. More than 6,000 delegates have been discussing the latest scientific developments in HIV science and how to put them into practice to combat the disease. In the medical

We can end AIDS, so let’s do it Read More »

B.C. government kicks off AIDS conference with funding announcement

Research facility will expand into large space on Vancouver’s Powell Street VANCOUVER — The B.C. government said it will put $2 million toward the Hope to Health Research Centre as a three-day international conference on the latest in HIV-related research opened Sunday in Vancouver. The fresh investment will allow the new HIV/AIDS, addiction and viral

B.C. government kicks off AIDS conference with funding announcement Read More »

B.C. supports expansion of Hope to Health Research Clinic

VANCOUVER – The Government of B.C. is providing St. Paul’s Hospital Foundation with $2 million to help the Hope to Health Research Clinic expand. Health Minister Terry Lake made the announcement in Vancouver last night at the eighth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), the world’s largest open scientific

B.C. supports expansion of Hope to Health Research Clinic Read More »

El tratamiento antirretroviral precoz beneficia a todos los afectados por VIH

Las personas infectadas por VIH tienen un riesgo menor de desarrollar sida u otras enfermedades graves si empiezan el tratamiento antirretroviral lo antes posible, cuando sus niveles de cŽlulas T CD4 -una medida clave de la salud del sistema inmunológico- son más altos, en lugar de esperar a que estos disminuyan. Esa es la conclusión

El tratamiento antirretroviral precoz beneficia a todos los afectados por VIH Read More »

FRANK TALK FROM JULIO MONTANER

FROM IAS 2015 BOB LEAHY SPEAKS (AGAIN) WITH BC’S DR. JULIO MONTANER, THE WORLD’S LEADING TREATMENT AS PREVENTION ADVOCATE, ABOUT 90-90-90, HIS FRUSTRATIONS WITH UPTAKE IN CANADA – AND MEETING THE POPE. He’s co-chair of IAS 2015, a conference of its time notable not so much for its presentation of the latest science but for

FRANK TALK FROM JULIO MONTANER Read More »

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025